Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1683 participants.
Also called NCT05047172
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,683 participants
- Sponsor
- Registry
-
NCT05047172
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05047172. Randomized; quadruple masking; primary purpose prevention. Start 2022-08-02 (actual); primary completion 2027-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
- Acronym
- CAPTIVA
- Condition
- Intracranial Arteriosclerosis
- Condition
- Stroke
- Intervention (Drug)
- Ticagrelor + Aspirin
- Intervention (Drug)
- Rivaroxaban + Aspirin
- Intervention (Drug)
- Clopidogrel + Aspirin
- Intervention (Other)
- Risk Factor Management
- Lead sponsor
- University of Florida
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator
- University of Cincinnati
- Collaborator
- Medical University of South Carolina
- Collaborator
- Janssen Scientific Affairs, LLC
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct05047172- Content hash
ee20421c5cbfcd29b0759bad33738aa28b6ceecb0d224d597fbcbc8c71ff84bb